Developer docs
API playgroundTry for free, no card

Search company profiles

ComInnex

Full company profile

uuid002u67r

Namestring
ComInnex
Websiteurl
cominnex.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

ComInnex is a privately held synthetic chemistry services provider founded in 2009 and headquartered in Budapest, Hungary. The company supplies synthetic chemistry services and novel chemical technologies to support early-stage drug discovery, positioning itself as a contract research partner for pharmaceutical and biotechnology organizations that require specialized chemistry capabilities in the hit-to-lead and lead optimization phases of drug development.

The firm operates at a micro-scale, with a reported headcount of 1-10 employees, indicating a boutique, expert-driven delivery model rather than a scaled platform CRO. Leadership is centered on CEO Alexander Drijver. Source material describing the company's specific product portfolio, proprietary platforms, technology stack, pricing structure, and customer base was not retrievable — the company website presented a security verification/loading page rather than substantive content during data collection. No funding rounds, partnerships, patents, certifications, or regulatory actions are documented in the available input.

ComInnex's business model is consistent with a fee-for-service contract research organization (CRO) operating in the synthetic chemistry niche, but no pricing details, contract structures, or revenue mechanics were available for verification. The firm is privately held and has not announced an IPO. As of the available data, the company appears to be a specialized, small-scale European chemistry services provider serving the early-stage drug discovery market.

Short descriptiontext

ComInnex is a Budapest-based synthetic chemistry services provider, founded in 2009, that delivers novel chemical technologies and chemistry expertise to pharmaceutical and biotech clients in early-stage drug discovery. The firm operates with a small team of 1-10 employees.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBudapest, Hungary
HQ citystring
Budapest
HQ countrystring
Hungary
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
synthetic chemistry services, drug discovery chemistry, contract research organization, medicinal chemistry, chemical library synthesis
Industry2 codes
PRIMARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Medicinal Chemicals & Botanical Products2833
Product category
Drug Discovery Chemistry Services
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ComInnex provides synthetic chemistry services and develops novel chemical technologies to support early-stage drug discovery. The company's work underpins compound preparation, route development, and chemistry-enabled discovery activities performed on behalf of pharmaceutical and biotechnology clients.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Synthetic chemistry services for drug discovery
CategoryDrug Discovery Chemistry Services
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Selvita is a Krakow, Poland-based contract research organization offering medicinal chemistry, custom synthesis, and integrated drug discovery services to biotech and pharma clients — directly comparable to ComInnex as a Central/Eastern European specialty chemistry CRO.

TypeDirect peer
Description

ChemPartner is a global CRO with strong synthetic and medicinal chemistry capabilities serving early-stage drug discovery programs, directly competing for the same biotech client base as ComInnex with comparable custom synthesis offerings.

TypeBroad incumbent
Description

Pharmaron is a large global CRO offering end-to-end drug discovery and development services including synthetic and medicinal chemistry — overlaps with ComInnex's chemistry offerings but operates at much greater scale across multiple geographies.

TypeDirect peer
Description

Sygnature Discovery is a UK-based drug discovery CRO offering medicinal chemistry, computational chemistry, and DMPK services, comparable to ComInnex in providing synthetic chemistry support for early-stage drug discovery.

TypeDirect peer
Description

Sai Life Sciences is an India-headquartered CRO providing medicinal chemistry, process chemistry, and integrated discovery services for pharma and biotech — directly comparable to ComInnex in offering synthetic chemistry support for early-stage drug discovery.

TypeBroad incumbent
Description

Eurofins Discovery is a global discovery services arm of Eurofins Scientific offering medicinal chemistry, custom synthesis, and screening services — comparable in service offering to ComInnex but with a much broader portfolio and global reach.

TypeDirect peer
Description

Aragen (formerly GVK Biosciences) is an India-based CRO offering medicinal chemistry, custom synthesis, and integrated discovery services — directly competing with ComInnex for early-stage drug discovery chemistry programs.

TypeDirect peer
Description

Concept Life Sciences is a UK-based discovery CRO providing medicinal chemistry, custom synthesis, and integrated drug discovery services — closely comparable to ComInnex as a mid-sized chemistry-focused discovery services provider.

TypeBroad incumbent
Description

Charles River Laboratories is a major global CRO with discovery and safety assessment services including synthetic chemistry — competes with ComInnex for chemistry services but operates as a much larger, broader incumbent with a full service portfolio.

TypeDirect peer
Description

BioAscent is a UK-based integrated drug discovery CRO with medicinal chemistry, DMPK, and biology services — comparable to ComInnex as a similarly sized specialist discovery services firm serving biotech clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ComInnex

Drug Discovery Chemistry Servicescominnex.com

ComInnex is a Budapest-based synthetic chemistry services provider, founded in 2009, that delivers novel chemical technologies and chemistry expertise to pharmaceutical and biotech clients in early-stage drug discovery. The firm operates with a small team of 1-10 employees.

What ComInnex does

ComInnex is a privately held synthetic chemistry services provider founded in 2009 and headquartered in Budapest, Hungary. The company supplies synthetic chemistry services and novel chemical technologies to support early-stage drug discovery, positioning itself as a contract research partner for pharmaceutical and biotechnology organizations that require specialized chemistry capabilities in the hit-to-lead and lead optimization phases of drug development.

The firm operates at a micro-scale, with a reported headcount of 1-10 employees, indicating a boutique, expert-driven delivery model rather than a scaled platform CRO. Leadership is centered on CEO Alexander Drijver. Source material describing the company's specific product portfolio, proprietary platforms, technology stack, pricing structure, and customer base was not retrievable — the company website presented a security verification/loading page rather than substantive content during data collection. No funding rounds, partnerships, patents, certifications, or regulatory actions are documented in the available input.

ComInnex's business model is consistent with a fee-for-service contract research organization (CRO) operating in the synthetic chemistry niche, but no pricing details, contract structures, or revenue mechanics were available for verification. The firm is privately held and has not announced an IPO. As of the available data, the company appears to be a specialized, small-scale European chemistry services provider serving the early-stage drug discovery market.

ComInnex firmographics

Firmographics
Name
ComInnex
Website
https://cominnex.com
Company type
Private
Founded year
2006
Headcount range
1–10 employees
Short description
ComInnex is a Budapest-based synthetic chemistry services provider, founded in 2009, that delivers novel chemical technologies and chemistry expertise to pharmaceutical and biotech clients in early-stage drug discovery. The firm operates with a small team of 1-10 employees.
Ownership category
akta.pro rank

ComInnex industry classification

Industry
Product category
Drug Discovery Chemistry Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Synthetic chemistry services
  • Drug discovery chemistry
  • Contract research organization
  • Medicinal chemistry
  • Chemical library synthesis

Where ComInnex is headquartered

Location

Headquarters

HQ city
Budapest
HQ country
Hungary
HQ region
Europe

Markets served

ComInnex business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

ComInnex product offering

Product offering

Core offering

ComInnex provides synthetic chemistry services and develops novel chemical technologies to support early-stage drug discovery. The company's work underpins compound preparation, route development, and chemistry-enabled discovery activities performed on behalf of pharmaceutical and biotechnology clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Synthetic chemistry services for drug discovery

Companies that use ComInnex

Customer profile

Ideal customer profiles1 record

ComInnex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ComInnex partnerships and signals

Strategic signal

Recent moves2 records

ComInnex competitors and assessment

Company assessment

Direct peers

  • Selvita: Selvita is a Krakow, Poland-based contract research organization offering medicinal chemistry, custom synthesis, and integrated drug discovery services to biotech and pharma clients — directly comparable to ComInnex as a Central/Eastern European specialty chemistry CRO.
  • ChemPartner: ChemPartner is a global CRO with strong synthetic and medicinal chemistry capabilities serving early-stage drug discovery programs, directly competing for the same biotech client base as ComInnex with comparable custom synthesis offerings.
  • Sygnature Discovery: Sygnature Discovery is a UK-based drug discovery CRO offering medicinal chemistry, computational chemistry, and DMPK services, comparable to ComInnex in providing synthetic chemistry support for early-stage drug discovery.
  • Sai Life Sciences: Sai Life Sciences is an India-headquartered CRO providing medicinal chemistry, process chemistry, and integrated discovery services for pharma and biotech — directly comparable to ComInnex in offering synthetic chemistry support for early-stage drug discovery.
  • Aragen Life Sciences: Aragen (formerly GVK Biosciences) is an India-based CRO offering medicinal chemistry, custom synthesis, and integrated discovery services — directly competing with ComInnex for early-stage drug discovery chemistry programs.
  • Concept Life Sciences: Concept Life Sciences is a UK-based discovery CRO providing medicinal chemistry, custom synthesis, and integrated drug discovery services — closely comparable to ComInnex as a mid-sized chemistry-focused discovery services provider.
  • BioAscent: BioAscent is a UK-based integrated drug discovery CRO with medicinal chemistry, DMPK, and biology services — comparable to ComInnex as a similarly sized specialist discovery services firm serving biotech clients.

Broad incumbents

  • Pharmaron: Pharmaron is a large global CRO offering end-to-end drug discovery and development services including synthetic and medicinal chemistry — overlaps with ComInnex's chemistry offerings but operates at much greater scale across multiple geographies.
  • Eurofins Discovery: Eurofins Discovery is a global discovery services arm of Eurofins Scientific offering medicinal chemistry, custom synthesis, and screening services — comparable in service offering to ComInnex but with a much broader portfolio and global reach.
  • Charles River Laboratories: Charles River Laboratories is a major global CRO with discovery and safety assessment services including synthetic chemistry — competes with ComInnex for chemistry services but operates as a much larger, broader incumbent with a full service portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

ComInnex social profiles

Digital presence

ComInnex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ComInnex leadership team

Management profile

Number of profiles

Profiles1 record

ComInnex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ComInnex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ComInnex

What does ComInnex do?

ComInnex provides synthetic chemistry services and develops novel chemical technologies to support early-stage drug discovery. The company's work underpins compound preparation, route development, and chemistry-enabled discovery activities performed on behalf of pharmaceutical and biotechnology clients.

When was ComInnex founded?

ComInnex was founded in 2006. It employs 1 to 10 people.

Where is ComInnex based?

ComInnex is headquartered in Budapest, Hungary, in the Europe region.

Who are ComInnex's main competitors?

Direct peers on record are Selvita, ChemPartner, Sygnature Discovery, Sai Life Sciences, Aragen Life Sciences, Concept Life Sciences and BioAscent. Broad incumbents are Pharmaron, Eurofins Discovery and Charles River Laboratories.

Does ComInnex have an API?

No public API is recorded for ComInnex.

What industry is ComInnex in?

ComInnex's product category is Drug Discovery Chemistry Services. Its primary akta.pro industry code is HLAGAHAE, Chiral / Asymmetric Synthesis & Complex Chemistry Services, with a secondary code of HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireComInnex Inc. announces ISO 9001:2015 certification - Global chemistry service and research organization reinforces its commitment to deliver the highest quality services to the life science industryComInnex announced it has obtained ISO 9001:2015 certification, extending its prior ISO 9001:2008 accreditation. The CEO said the certification provides assurance of continuous improvement and customer satisfaction. The company, a chemistry service provider, aims to maintain high-quality operations for its global customers.GlobeNewswireInnoStudio, ComInnex and ThalesNano enter into photochemistry collaboration with Technical University EindhovenInnoStudio, ComInnex, and ThalesNano entered a research and development collaboration with Professor Tim Noël's group at the Eindhoven University of Technology. The partnership focuses on photoreactor technologies, photoredox catalysis for medicinal chemistry, and space chemistry applications. The collaboration is expected to lead to new flow photoreactors and novel compound designs.GlobeNewswireComInnex - Chemistry Innovation 2017 ReviewComInnex announced its 2017 review, reporting strong growth in revenues and EBITDA from ongoing and new projects with major pharmaceutical companies. Its FTE and Fee for Services custom chemistry division grew 40%, and it entered a collaborative drug discovery project with two Hungarian universities for oncology candidates.PR NewswireJahresbericht zu DarholdingDarholding Ltd., a Budapest-based innovation incubator operating in pharmaceuticals, agrochemicals, fine chemicals, flavors and fragrances, laboratory instruments, and space chemistry, reported a 57% year-over-year increase in consolidated EBITDA and a 5% rise in group revenue to €9.6 million for the fiscal year. The company secured three EU grants, with subsidiary Thalesnano receiving the largest allocation of over $4 million for hydrogen technology and CO2 sequestration projects, while subsidiary ComInnex expanded its partnership model with major pharmaceutical companies. Darholding filed three patent applications in the US and had more than five patents granted worldwide, while co-hosting the world's first and second space chemistry symposiums with the American Chemical Society.